Jci_page_head_homepage_01 Jci_page_head_homepage_02
Terry K. Means, Eicke Latz, Fumitaka Hayashi, Mandakolathur R. Murali, Douglas T. Golenbock, Andrew D. Luster
Published in Volume 115, Issue 2
J Clin Invest. 2005; 115(2):407–417 doi:10.1172/JCI23025
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 8

CD32 delivers anti-DNA ICs to TLR9-containing lysosomes. U373 cells coexpressing YFP-tagged TLR9 (red) and CFP-tagged CD32 (green) were incubated with Alexa Fluor 633–conjugated (blue) anti-DNA ICs (A), Alexa Fluor 633–conjugated non–SLE-ICs (B), or Alexa Fluor 633–conjugated IgG (C) for 5 minutes, and living cells were imaged by confocal microscopy. (D) Cells expressing TLR9-CFP (red) and CD32-CFP (green) were incubated with lysotracker (blue).